University of Chicago (Site 850) — Chicago, Illinois

University of Chicago (Site 850) is a clinical research site located in Chicago, Illinois, United States 60637.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

University of Chicago (Site 850) has participated in 2 clinical trials.

Therapeutic areas: NF1, Low-grade Glioma, Neurofibromatosis 2.

Sponsors: University of Alabama at Birmingham.

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Chicago (Site 850)?

University of Chicago (Site 850) has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Chicago (Site 850) conducted?

University of Chicago (Site 850) has 2 clinical trials on record. Their work covers NF1, Low-grade Glioma, Neurofibromatosis 2.

Is University of Chicago (Site 850) accredited by Crixeo Health?

University of Chicago (Site 850) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Chicago (Site 850)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.